The Cooper Companies, Inc. filings document a Nasdaq-listed medical device company with common stock trading under the symbol COO. Its regulatory disclosures include Form 8-K reports on quarterly results, board and officer changes, annual meeting voting results, and material definitive agreements, including amendments to term loan arrangements.
Proxy materials describe director elections, board committee matters, executive compensation, shareholder proposals, and governance practices. Together, the filings record operating and financial disclosures for CooperVision and CooperSurgical, capital structure information, debt arrangements, stockholder voting mechanics, and risk and governance topics relevant to the company’s contact lens, fertility, and women’s healthcare businesses.
The Cooper Companies, Inc. reported third-quarter fiscal 2025 results showing continued activity across acquisitions, financing and operations. The company completed acquisitions including obp Surgical for $100.0 million and a fertility company for $33.5 million in 2024, and earlier acquired select Cook Medical assets for $300.0 million (present value $291.6 million). Consolidated gross margin was 65% for the quarter (66% prior-year quarter) driven lower primarily by inventory write-offs related to a product line exit.
Liquidity and capital: working capital was $1,127.7 million versus $928.7 million a year earlier. Total outstanding debt carried an aggregate amount of $2.5 billion; $930.2 million was outstanding on the 2024 Revolving Credit Facility at a weighted-average interest rate of 5.43% and $1,500.0 million remained under the 2021 Term Loan. Share repurchases in the quarter totaled 0.7 million shares for $52.2 million, with $163.6 million remaining authorized. Management disclosed a material weakness in IT general controls impacting CooperSurgical and is implementing remediation steps.
The Cooper Companies, Inc. furnished a current report to disclose that it issued a press release announcing its results for the fiscal third quarter ended July 31, 2025.
The press release, dated August 27, 2025, is provided as Exhibit 99.1 and is incorporated by reference into this report, but is designated as “furnished” rather than “filed” under securities laws. The company also includes an Inline XBRL cover page data file as Exhibit 104.1, and the report is signed by President and Chief Executive Officer Albert G. White III.